Association between fluoroquinolone exposure and children's growth and development: A multisite biomonitoring-based

Lixin Shan1, Ming Gao2, Xiaohua Pan3

  • 1College of Marine Life Sciences, Ocean University of China, Qingdao, 266003, China.

Insights

Veterinary antibiotic exposure, specifically enrofloxacin, is linked to increased overweight and obesity risk in children. This study highlights the need for careful fluoroquinolone use and disposal to protect child health.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Toxicology

Background:

  • Limited human data exists on veterinary antibiotic exposure's impact on child development.
  • Animal studies suggest early-life antibiotic exposure increases adiposity.

Purpose of the Study:

  • To measure fluoroquinolone body burden in northern Chinese children.
  • To assess the association between antibiotic exposure and children's growth and development.

Main Methods:

  • Urinary fluoroquinolone concentrations (fleroxacin, ofloxacin, norfloxacin, ciprofloxacin, enrofloxacin) were measured in 233 children (0-15 years).
  • Children's growth was categorized using body mass index Z scores.
  • Health risks were estimated using hazard quotient (HQ) and hazard index (HI).
  • Logistic regression analyzed the association between antibiotic levels and growth outcomes.

Main Results:

  • Four fluoroquinolones were detected in 57.08% of samples, with varying concentrations by region.
  • Ciprofloxacin exposure posed potential health risks (HQ > 1 in 20.61% of participants).
  • Hazard index exceeded 1 in 23.18% of samples.
  • Middle-concentration enrofloxacin exposure was associated with a 3.01-fold increased risk of overweight or obesity.

Conclusions:

  • This is the first study linking enrofloxacin exposure to increased overweight/obesity risk in children.
  • Increased attention to fluoroquinolone usage and disposal is crucial for safeguarding children's health.
Abstract

Related Concept Videos